Combination therapy with an angiotensin converting enzyme inhibitor and an angiotensin-II receptor antagonist for refractory essential hypertension.
作者信息
Bisognano J D, Horwitz L D
机构信息
Division of Cardiology, University of Colorado Health Sciences Center, Denver, USA.
出版信息
West J Med. 1998 Apr;168(4):272-4.
Abstract
摘要
相似文献
1
2
[Antihypertensive therapy using a combination of angiotensin 1 receptor inhibitors with angiotensin-converting enzyme inhibitors].
Dtsch Med Wochenschr. 1998 May 22;123(21):681.
3
[Combination therapy with ACE inhibitors and angiotensin receptor antagonists].[血管紧张素转换酶抑制剂与血管紧张素受体拮抗剂联合治疗]
Internist (Berl). 1999 Jun;40(6):678-9.
4
[Combination therapy with angiotensin receptor blockers and ACE inhibitors - pro].
Dtsch Med Wochenschr. 2009 Nov;134(45):2294. doi: 10.1055/s-0029-1241942. Epub 2009 Oct 29.
5
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.原发性醛固酮增多症所致高血压中血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂：排除的理由。
Ann Pharmacother. 2007 Jan;41(1):129-32. doi: 10.1345/aph.1H456. Epub 2006 Dec 19.
6
Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂在高血压患者心肌梗死一级预防中的比较。
Am J Cardiol. 2004 Aug 15;94(4):479-81. doi: 10.1016/j.amjcard.2004.04.063.
7
8
[Antihypertensive therapy using a combination of angiotensin-1 receptor inhibitors and angiotensin-converting enzyme inhibitors].
Dtsch Med Wochenschr. 1998 Oct 23;123(43):1295.
9
[Combination therapy with angiotensin receptor blockers and ACE inhibitors - contra].[血管紧张素受体阻滞剂与ACE抑制剂联合治疗——禁忌]
Dtsch Med Wochenschr. 2009 Nov;134(45):2295. doi: 10.1055/s-0029-1241943. Epub 2009 Oct 29.
10
Progress in the development of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的研发进展。
Curr Opin Investig Drugs. 2005 Mar;6(3):269-74.
引用本文的文献
1
Combination ACE inhibitor and angiotensin receptor blocker therapy - future considerations.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂联合治疗——未来的考量
J Clin Hypertens (Greenwich). 2007 Jan;9(1):78-86. doi: 10.1111/j.1524-6175.2007.6359.x.
2
Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy: its role in clinical practice.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂联合治疗：其在临床实践中的作用。
J Clin Hypertens (Greenwich). 2003 Nov-Dec;5(6):414-20. doi: 10.1111/j.1524-6175.2003.02836.x.
3
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in combination: theory and practice.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂联合应用：理论与实践
J Clin Hypertens (Greenwich). 2001 Nov-Dec;3(6):383-7. doi: 10.1111/j.1524-6175.2001.00678.x.
4
Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.比较血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂的治疗试验。
Curr Hypertens Rep. 2000 Aug;2(4):402-11. doi: 10.1007/s11906-000-0045-8.
5
The renin-angiotensin system antagonism in the treatment of hypertension.肾素-血管紧张素系统拮抗作用在高血压治疗中的应用
Curr Hypertens Rep. 1999 Aug;1(4):275-7. doi: 10.1007/s11906-999-0033-6.
本文引用的文献
1
Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.依那普利和氯沙坦可减轻自发性高血压大鼠的心脏重量，并改善其冠状动脉血流动力学。
Hypertension. 1997 Jan;29(1 Pt 2):519-24. doi: 10.1161/01.hyp.29.1.519.
2
Angiotensin receptors and their antagonists.
N Engl J Med. 1996 Jun 20;334(25):1649-54. doi: 10.1056/NEJM199606203342507.
3
Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.氨氯地平和喹那普利对高血压患者动态血压及血小板功能的比较
J Hum Hypertens. 1995 Aug;9(8):637-41.
4
The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.人类的糜酶 - 血管紧张素系统：生物化学、分子生物学及其在心血管疾病中的潜在作用。
Can J Cardiol. 1995 Aug;11 Suppl F:13F-19F.
5
Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.完整人体心脏中血管紧张素II的形成。血管紧张素转换酶途径占主导地位。
J Clin Invest. 1995 Sep;96(3):1490-8. doi: 10.1172/JCI118186.
6
Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.血管紧张素转换酶抑制与血管紧张素II拮抗联合应用对钠缺乏正常血压者血压及肾素释放的相加作用
Circulation. 1995 Aug 15;92(4):825-34. doi: 10.1161/01.cir.92.4.825.
7
Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.喹那普利。对其在心血管疾病中的药理学和治疗效果的重新评估。
Drugs. 1994 Aug;48(2):227-52. doi: 10.2165/00003495-199448020-00008.
8
Long-term enalapril--a new converting enzyme inhibitor--in the treatment of mild to moderate essential hypertension, results of a worldwide multiclinic study. Comparing two ways of analyzing data.
Clin Exp Hypertens A. 1985;7(11):1515-39. doi: 10.3109/10641968509073607.
9
Different distribution of two types of angiotensin II-generating enzymes in the aortic wall.
Biochem Biophys Res Commun. 1987 Dec 31;149(3):1186-92. doi: 10.1016/0006-291x(87)90533-x.
10
Angiotensin II-forming pathways in normal and failing human hearts.正常和衰竭的人类心脏中血管紧张素II的生成途径。
Circ Res. 1990 Apr;66(4):883-90. doi: 10.1161/01.res.66.4.883.
Zotero 插件